Search results
Pfizer's Hospira Recalls Select Hydrochloride Injection Carpuject Units
RTT News· 22 hours agoHospira, Inc., affiliated to dug major Pfizer Inc., is recalling select lots of Buprenorphine Hydrochloride Injection Carpuject Units and Labetalol Hydrochloride Injection ...
How the love story between von der Leyen and Pfizer turned sour
Euronews via Yahoo News· 7 days agoFrom making her Europe’s vaccine saviour to becoming a skeleton in her closet: All the ebbs and...
Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It
Zacks via Yahoo Finance· 7 days agoPfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might...
Pfizer targets $1.5 billion in savings by 2027 as it streamlines operations
WSAU Wausau· 2 days ago(Reuters) -U.S. drugmaker Pfizer said on Wednesday it had launched a multi-year program to reduce...
BioMérieux, Pfizer, Malawi Ministry of Health Collaborate on Antimicrobial Resistance Effort
GenomeWeb News· 18 hours agoBioMérieux announced on Thursday that it has formed a collaboration with Pfizer and the Malawi Ministry of Health to address antimicrobial resistance in the African nation ...
Pfizer wins cancer drug patent case against AstraZeneca
Pharmaceutical Technology via Yahoo Finance· 4 days agoThe US District Court for the District of Delaware has ordered AstraZeneca to pay $107.5m to Pfizer...
Zantac not a cause of woman’s cancer, jury says in first trial over drug
Reuters via Yahoo News· 15 hours agoA jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn...
The Flash May PMI Report Claps Back on Rate Cut Expectations
TheStreet.com· 15 hours agoThe data shows an upturn in the economy with inflation pressures not backing down. * The Flash May...
Pfizer to Cut Costs in Multi-Year Effort
The Wall Street Journal· 2 days agoThe company said it estimates savings of $1.5 billion in the plan’s first phase by the end of 2027.
3 Biotech Stocks to Buy on the Dip: May 2024
InvestorPlace· 14 hours agoDespite their exciting growth potential and undeniable rewards, investors have been selling these stocks, causing a slight dip in price. Pfizer (NYSE:PFE) is a giant in biopharma ...